| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 2058 |
| 1 | NEMOLIZUMAB-ILTO | 222 |
| 2 | GABAPENTIN | 80 |
| 3 | LEVOTHYROXINE SODIUM | 70 |
| 4 | ERGOCALCIFEROL | 67 |
| 5 | PREDNISONE | 60 |
| 6 | ACETAMINOPHEN | 58 |
| 7 | ADALIMUMAB | 57 |
| 8 | HYDROXYZINE | 57 |
| 9 | CETIRIZINE HYDROCHLORIDE | 52 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ICHTHAMMOL OINTMENT | 5 | 0.1351 |
| 1 | GLYCERIN, LIDOCAINE, PETROLATUM, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0556 |
| 2 | NEMOLIZUMAB-ILTO | 222 | 0.0224 |
| 3 | MENTHOL AND BENZOCAINE | 1 | 0.0189 |
| 4 | MOEXIPRIL HYDROCHLORIDE | 1 | 0.0149 |
| 5 | AMCINONIDE | 1 | 0.0119 |
| 6 | ASPRIN AND CAFFEINE | 1 | 0.0082 |
| 7 | HALOBETASOL PROPIONATE AND TAZAROTENE | 1 | 0.0051 |
| 8 | HYDROCORTISONE VALERATE | 3 | 0.0051 |
| 9 | PRAMOXINE HYDROCHLORIDE, MENTHOL | 1 | 0.0051 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2058 |
| 1 | Interleukin-31 Receptor alpha Antagonist [EPC] | 222 |
| 2 | Corticosteroid [EPC] | 187 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 158 |
| 4 | Benzodiazepine [EPC] | 105 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 68 |
| 6 | Provitamin D2 Compound [EPC] | 67 |
| 7 | Proton Pump Inhibitor [EPC] | 63 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 61 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 50 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-31 Receptor alpha Antagonist [EPC] | 222 | 0.0224 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2058 | 0.0047 |
| 2 | alpha-Hydroxy Acid [EPC] | 8 | 0.0040 |
| 3 | Sclerosing Agent [EPC] | 1 | 0.0023 |
| 4 | Thyroid Hormone Receptor beta Agonist [EPC] | 2 | 0.0013 |
| 5 | RNA Synthetase Inhibitor Antibacterial [EPC] | 17 | 0.0013 |
| 6 | Interleukin-13 Antagonist [EPC] | 7 | 0.0010 |
| 7 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 3 | 0.0009 |
| 8 | Paramagnetic Contrast Agent [EPC] | 4 | 0.0009 |
| 9 | Calcitonin [EPC] | 2 | 0.0006 |